Allergy Therapeutics PLC banner

Allergy Therapeutics PLC
OTC:AGYTF

Watchlist Manager
Allergy Therapeutics PLC Logo
Allergy Therapeutics PLC
OTC:AGYTF
Watchlist
Price: 0.11 USD Market Closed
Market Cap: $524.3m

Relative Value

The Relative Value of one AGYTF stock under the Base Case scenario is hidden USD. Compared to the current market price of 0.11 USD, Allergy Therapeutics PLC is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

AGYTF Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

AGYTF Competitors Multiples
Allergy Therapeutics PLC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
UK
Allergy Therapeutics PLC
OTC:AGYTF
737m USD 13.1 -18 -31.1 -26.5
US
Eli Lilly and Co
NYSE:LLY
986.9B USD 15.1 47.8 32.2 34.4
US
Johnson & Johnson
NYSE:JNJ
596.5B USD 6.3 22.3 15.4 19
CH
Roche Holding AG
SIX:ROG
283.9B CHF 4.6 30.3 12.8 14.9
CH
Novartis AG
SIX:NOVN
247.6B CHF 5.7 22.9 14.1 18.2
UK
AstraZeneca PLC
LSE:AZN
238.1B GBP 5.5 31.5 17.4 24.5
US
Merck & Co Inc
NYSE:MRK
305.9B USD 4.7 16.8 10.4 12.6
IE
Endo International PLC
LSE:0Y5F
218B USD 94 -74.6 344.9 865
DK
Novo Nordisk A/S
CSE:NOVO B
1T DKK 3.4 10.3 7.6 8.9
US
Pfizer Inc
NYSE:PFE
156.9B USD 2.5 20.2 7.7 10.3
US
Bristol-Myers Squibb Co
NYSE:BMY
125.6B USD 2.6 17.8 7.4 9.2
P/E Multiple
Earnings Growth PEG
UK
Allergy Therapeutics PLC
OTC:AGYTF
Average P/E: 24.4
Negative Multiple: -18
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
47.8
28%
1.7
US
Johnson & Johnson
NYSE:JNJ
22.3
7%
3.2
CH
Roche Holding AG
SIX:ROG
30.3
29%
1
CH
Novartis AG
SIX:NOVN
22.9
15%
1.5
UK
AstraZeneca PLC
LSE:AZN
31.5
26%
1.2
US
Merck & Co Inc
NYSE:MRK
16.8
14%
1.2
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -74.6 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
10.3
7%
1.5
US
Pfizer Inc
NYSE:PFE
20.2
26%
0.8
US
Bristol-Myers Squibb Co
NYSE:BMY
17.8
17%
1
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
UK
Allergy Therapeutics PLC
OTC:AGYTF
Average EV/EBITDA: 47
Negative Multiple: -31.1
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
32.2
22%
1.5
US
Johnson & Johnson
NYSE:JNJ
15.4
2%
7.7
CH
Roche Holding AG
SIX:ROG
12.8
5%
2.6
CH
Novartis AG
SIX:NOVN
14.1
5%
2.8
UK
AstraZeneca PLC
LSE:AZN
17.4
13%
1.3
US
Merck & Co Inc
NYSE:MRK
10.4
3%
3.5
IE
E
Endo International PLC
LSE:0Y5F
344.9
N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
7.6
2%
3.8
US
Pfizer Inc
NYSE:PFE
7.7
-9%
N/A
US
Bristol-Myers Squibb Co
NYSE:BMY
7.4
-10%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
UK
Allergy Therapeutics PLC
OTC:AGYTF
Average EV/EBIT: 101.7
Negative Multiple: -26.5
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
34.4
22%
1.6
US
Johnson & Johnson
NYSE:JNJ
19
7%
2.7
CH
Roche Holding AG
SIX:ROG
14.9
6%
2.5
CH
Novartis AG
SIX:NOVN
18.2
9%
2
UK
AstraZeneca PLC
LSE:AZN
24.5
21%
1.2
US
Merck & Co Inc
NYSE:MRK
12.6
6%
2.1
IE
E
Endo International PLC
LSE:0Y5F
865
N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
8.9
3%
3
US
Pfizer Inc
NYSE:PFE
10.3
-4%
N/A
US
Bristol-Myers Squibb Co
NYSE:BMY
9.2
-7%
N/A
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett